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1 Introduction
Maternal serum alpha fetoprotein (MSAFP)
screening is able to detect virtually all anencephalic
fetuses, a majority of open spina biflda cases, and
about one half of abdominal wall defects [1]. Re-
cent evidence also suggests that MSAFP screening
may also assist in the prenatal diagnosis of Down
syndrome and other trisomy abnormalities [2, 8].
These observations have resulted in a dramatic
increase in the number of physician request for
MSAFP measurements as well as an upsurge in
the number of clinical laboratories performing this
test. However, MSAFP screening involves much
more than performing an assay and reporting a
result. The clinical laboratory must not only pro-
vide an AFP result but also interpret the result,
recommend appropriate action to be taken based
on the result and provide a mechanism for appro-
priate follow-up, to document pregnancy outcome
[6]. Moreover, due to the gestational age-depend-
ent nature of AFP, and the reported effects of
maternal status (such as age, weight and IDDM)
on the result, the MSAFP laboratory report needs
an interpretation and recommendation specifically
tailored for each patient. This requires the clinical
laboratory performing the MSAFP test to obtain
and maintain an adequate data base on the patient
being tested, integrate this data base with the AFP
result, and provide the physician with a report
based on this integration. In this paper we report
on the development of a computer program which
assists the MSAFP screening laboratory in meet-
ing these criteria. This program, written in BASIC,
1) maintains a data base for patients tested, 2)
allows input and storage of MSAFP results, 3)
calculates the gestational age dependent result in
multiples of the median (MOM), 4) makes an
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individualized interpretation of the result based on
maternal age, weight and IDDM, 5) makes an
appropriate recommendation for subsequent ac-
tion based on the result, and 6) prints a report
containing the above information. In addition, the
program prints a daily log of patients tested, pro-
vides a follow-up sheet to assist in tracking ab-
normal results to term, updates the median values
on different gestational ages at regular intervals,
provides epidemiological data on positive and neg-
ative screening rates to be utilized as quality con-
trol measurements, and generates a monthly state-
ment for billing purposes. The data base files are
simple random access files which can be addressed
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for statistical manipulation and examination. The
data files can also be easily intergrated into more
powerful data base programs. The program can
be easily modified by someone with minimal train-
ing in the BASIC programing language. To date
this program has been successfully used in the
analysis of over 6300 MSAFP samples.
2 Description of the program
2.1 Hardware
The computer used for this program is an IBM
PC AT having 640K RAM, a color monitor, and
IBM PC-DOS 3.1 operating system. The BASIC
program and the patient data base files are stored
in the hard disk drive. A standard double sided,
double density 5 1//4 inch floppy diskette can hold
approximately 3000 patients. The program was
originally written far an IBM PC with 256K
RAM. However, it was later discovered that the
on board memory was not sufficient to handle the
monthly billing statement generating portion of
the program.
2.2 Software
The MSAFP software was programmed in IBM
BASIC A by the authors and consists of approx-
imately 930 lines of programing (see Appendix).
The patient data base information is stored in
random access files with a record length of 113
characters per file. The following information is
stored for each patient in the data file: patient
name, age, weight, diabetes, doctor's name, doc-
tor's billing code, date sample was drawn, whether
sample is a repeat or first run, whether sample is
serum or amniotic fluid, date sample was assayed,
gestational age determined by last menstrual pe-
riod (LMP), gestational age determined by ultra-
sound (USG), the AFP value, and the location of
the refering physician or laboratory. Physicians
are instructed to complete a requisition to provide
the above information on each patient. This re-
quisition along with the sample is delivered to the
laboratory. Each sample presented to the labora-
tory for MSAFP testing is assigned the next avail-
able accession number (sample code). This code
number correlates with the patients data base re-
cord number, and is used to access the patient's
file.
The program is completely menu driven. From the
main menu the user may choose one of eight
options:
Input new patient data (2.2.1)
Input MSAFP results (2.2.2)
Print reports from stored data base (2.2.3)
Edit a stored file (2.2.4)
Print a patient log (2.2.5)
Print patient follow-up sheet (2.2.6)
Sort patients for billing (2.2.7)
Create data base files (2.2.8)
2.2.1 Input new patient data: Table I shows the
screen for patient data base input and the infor-
mation which can be entered. Most samples are
not from insulin-dependent diabetic patients and
are not repeats, so these values are set to default
as a "no" answer (brackets). The report date is
also defaulted to a date entered initially to save
entry time. Once the patient data base information
has been entered, the user has the option to store
the information as entered, edit the information,
or print a report. If a printed report is chosen, the
gestational-age dependent MOM will be retrieved,
the weight adjusted MOM calculated, an interpre-
tation and recommendation chosen and the report
will be generated (see below). The data base in-
formation is then stored in the random access file.
2.2.2 Input MSAFP results: It is often convenient
to input the patient data base information into
the computer before the actual MSAFP values are
obtained. Patient information can then be logged
onto the computer as soon as specimens arrive if
this occurs prior to the time of the assay. The
Input MSAFP Results option asks the user for the
number of stored patients which require the ad-
dition of MSAFP value. The user is then prompted
to enter the patients code number followed by the
MSAFP value. Once this is completed, the pro-
gram automatically recalls each patient's data base
and inserts the MSAFP value. Thus, to enter a
number of MSAFP values the user may use this
option rather than recalling each data base indi-
vidually and editing in the value.
2.2.3 Print reports from stored data base: This is
the major calculation and data interpretation rou-
tine of the program. The user is first prompted
for the number of reports needed, and is then
asked to enter the sample code numbers in any
order. The program then recalls the patients data
base according to the sample code. The program
then generates the report by first printing the
patients name and other pertinent information
contained in the data base (table II). If the mater-
nal age and/or weight are not available, an asterisk
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Age: yrs. Draw Date://, Repeat Draw: [no]
Weight: Ibs. Location: [Wichita]
Diabetes: [no] Report Date: [10/25/88]
Sample Code: Gest Age LMP: wks, USG: wks
AFP Value: lU/ml
Table Π. Example report form generated for a normal MSAFP result
Name: Doe, Jane Doctor: Smith
Age: 24, Weight: 235 Ibs. Location: Wichita
Draw Date: 10/20/88 Report Date: 10/24/88
Diabetes: no Dample: Serum
Repeat Draw: no Sample Code: 4000
Last Menstrual Period Ultrasound
Gestational Age: 22 weeks by LMP 18 weeks by USG
Assay Value: 34.17 lU/ml 34.17 lU/ml
Multiple of Median: 0.42 MOM 0.86 MOM
Weight Adjusted MOM: 0.74 MOM 1.49 MOM
Normal Range: .42 MOM to 2.5 MOM
Interpretation: This serum AFP value, adjusted for maternal weight, is within the normal rnge for a 24 year old
pregnant women at 18 weeks of gestation.
Recommendation: None.
Report Date:
Tech. Sechin Cho, M. D.
' Brooks A. Keel, Ph. D.
is printed in the respective locations on the report appropriate heading. The weight adjusted MOM
form and the physician is requested to provide the is then calculated (lines 1650 -1670, Appendix) by
laboratory with this information (see below). the formula [9]: Wt. Adj. MOM = MOM/(1.555
- 0.00417 χ Maternal Wt. in Ibs.). The observed
The next portion of the computer generated report MOM and the weight adjusted MOM is then
concerns the calculation of the result (table II). printed under the appropriate heading. The nor-
The MSAFP assay value and gestational age are mal range for the individual patient is determined
reported under a "Last Menstrual Period" and/or by the patients maternal age (low end) and the
"Ultrasound" heading, depending upon the presence of insulin dependent diabetes. If the pa-
method(s) used for gestational age determination, tient is < 21 years of age at the time of delivery,
The regressed assay multiple of the median the low normal MOM is reported as 0.38 MOM.
(MOM) values for each gestational age between As the patient increases in age, this low normal
14 and 25 weeks are written into the program as value increases and is adjusted on the report ac-
data statements (line 1620, Appendix). These val- cordingly. The actual values [8] are written into
ues are read into the program internally (line 1640, the program as data statements and are read in-
Appendix) and the MOM for the recorded gesta- ternally (lines 1680 — 1690, Appendix). If the pa-
tional age is determined and printed under the tient is reported as having insulin dependent dia-
J. Perinat. Med. 17 (1989)
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betes the upper normal limit is set at 2.0 MOM
[6, 11] otherwise the upper normal limit is 2.5
MOM [4].
The final section interprets the MSAFP value and
makes an appropriate recommendation. There are
eight possible interpretation and recommendation
subroutines. These are based on a normal result
(table II), < 14 weeks of gestational age, abnormal
low MSAFP (table III), abnormal high MSAFP
(table IV), abnormal repeat MSAFP, and no inter-
pretation possible due to lack of maternal age,
weight or gestational age. Because of increased
accuracy and reproducibility of USG determina-
tion of gestational age, USG information, if avail-
able, is used for the interpretation regardless of
the LMP data. If only LMP data is available, this
information is used for the interpretation. Also,
because of the reported differences in MSAFP
values due to excessive overweight or underweight
and the accompanying differences in maternal
blood volume [9], all interpretations are based on
the weight adjusted MOM.
The actual interpretations used for a normal, ab-
normal low or elevated MSAFP are presented in
tables II, III, and IV, respectively. If a repeat
MSAFP is also elevated, amniocentesis for am-
niotic fluid AFP and karyotype is recommended.
For abnormal low MSAFP results, the actual risk
for Down syndrome for that patient is determined
from a Down syndrome odds table [8] based on
the patient's age and the MOM value and is hand-
written on the report form (table III). In addition,
because the risk for fetal abnormality is signifi-
cantly great for women 35 years of age or older,
amniocentesis to rule out chromosomal abnor-
malities is recommended for patients 35 years or
older at the time of delivery even if the MSAFP
result is normal [3]. The end of the report form
provides space for the technician's initials and for
the laboratory director/geneticist signature and
date. Report forms are printed on continuous-feed
forms to allow unassisted operation in printing.
2.2.4 Edit a stored file. This option allows the
user to edit any portion of the patient's data base
already stored. This option is especially useful if
additional information, such as USG gestational
age, maternal weight or age, becomes available
after the initial reports are printed. Once the file
is edited, the user may store the edited data base
or request an updated report to be printed.
Table ΠΙ. Example MSAFP report form for an abnormally low MSAFP illustrating the results, interpretation and
recommendation sections of the report










.81 MOM to 2.5 MOM
Interpretation: The serum AFP value, adjusted for maternal weight, is low for a 35 year old pregnant women
at 17 weeks of gestation.
The risk of Down Syndrome in this pregnancy is greater than 1/270. Actual calculated risk
for this patient is I/
Recommendation: 1. An ultrasound study is indicated, if not done already, to rule out:
a. overestimated gestational age
b. missed abortion
c. molar pregnancy or non pregnancy
2. If gestational age is correct, amniocentesis is indicated to rule out Down Syndrome and
other chromosomal abnormalities.
Report Date:
Tech: Sechin Cho, M. D.
Brooks A. Keel, Ph. D.
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.51 NOM to 2.5 MOM
Interpretation: This serum value, adjusted for maternal weight, is elevated for a singleton pregnancy at 18
weeks of gestation.
Recommendation: Repeat MSAFP is recommended immediately along with complete sonogram, if not done
already, to rule out:
a. underestimated gestational age
b. multiple pregnancy
c. fetal demise or anomalies
Report Date:
Tech: Sechin Cho, M. D.
Brooks A. Keel, Ph. D.
2.2.5 Print a patient log: This option allows the
user to print a log of the patients assayed each
day. The user is asked to enter the first and last
sample codes to be logged. The program then
recalls each data base and prints the code number,
patient name, doctor's name, doctor's billing code,
and the draw date of each sample. This function
is particularly useful for generating a daily labo-
ratory log of patient samples assayed, which is
required by many state and federal laboratory
licensing agencies. This log is also helpful in track-
ing patient samples on a day to day basis.
2.2.6 Print patient follow-up sheet: Accurate and
comprehensive follow-up of patients who have
abnormal MSAFP results is mandatory for a
MSAFP screening program [5]. This option asks
the user for the sample code of the abnormal
result. The program then recalls and prints an
abbreviated report for this patient (table V). This
printed follow-up sheet contains space for input
of the results of ultrasound, repeat draw MSAFP,
amniocentesis, acetylcholinesterase assay, and re-
sults of delivery. This follow-up sheet can then be
filed and the record of this patient's progress main-
tained until the final outcome is known. This in-
formation is extremely important in determining
the laboratories false positive and false negative
predictive rates based on the MSAFP result and
pregnancy outcome.
2.2.7 Sort patients for billing: This option gen-
erates monthly billing statements. The user is
asked for the first and last sample code for those
samples run during the preceding month. The pro-
gram then recalls each patient's data base and
sorts the patients according to the doctor's billing
code subgroup, which is arbitrarily assigned by
the user. The physicians within each subgroup are
then arranged alphabetically according to the phy-
sician's last name. Once accomplished, the pro-
gram prints the patient name, doctor name, draw
date and sample code for each billing code. This
option generates an individual billing statement
for each physician, laboratory or clinic and pro-
vides not only a financial statement but a per-
manent record of patients assayed for each patient
referring group.
2.2.8 Create data base files: This option converts
the random access patient data file into data files
which can be intergrated into other more powerful
data base programs. The user is asked to enter the
first and last patient code number to convert. The
program then converts the random access file into
an individual sequential file specific for each var-
iable contained in the patient data base (patient
name, age, weight, assay value, etc.). The con-
verted sequential files are then stored onto a
floppy disk. The data can then be easily imported
into other commercially available data base pro-
grams, such as Lotus 123R or dBase IIIR.
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Table V. Example patient follow-up sheet
Name: Doe, Jane




Gest. Age: 0 wks by LMP






18 wks by USG
MOM = 9.78, Wt Con MOM = 70.29
Follow-Up
A. Ultrasound Date:.
1. Declined by Pt.:




MOM Wt Corr MOM.
5. Concurrent:
6. Abnormal:
B. Repeat Draw Date:.










1 Declined hy Pt.:
1. Ultrasound- wks hy USG
Findings:
3. AFAFP: Π I/ml, MOM
4. Karyotype:
R Infant Normal: DOB: G. A.:












The program described herein is extremely easy to
use yet powerful enough to address most of the
needs of a MSAFP screening program. The con-
cept behind the program satisfies the requirements
for a MSAFP laboratory by 1) providing an easily
accessible patient data base, 2) reporting a result
and providing an interpretation of the result and
recommendation for the individual patient, and 3)
allowing for patient follow-up. By writing the pro-
gram in the BASIC language, it can be easily
modified to suit individual needs by anyone with
a minimal amount of programing experience. The
random access patient data base files can be read-
ily addressed by other BASIC programs and al-
lows for statistical manipulation of the data. The
J. Perinat. Med. 17 (1989)
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Create Data Base Files option allows the patient
data base information to be incorporated into
other commercially available, more powerful data
base programs. We have found the report format
to be very advantageous and convenient for phy-
sicians. By tailoring the report for the individual
patient, the physician is able to rapidly assimilate
the information without having to compare the
observed result with a list of normal values for the
respective gestational age. When both the LMP
and USG gestational age data are available, we
report the results for both ages. Although our
interpretation and recommendation are based on
USG data when available, we felt it important to
provide the physician with both sets of data. When
only LMP data are available, our interpretation
and recommendations are based on these data,
allowing the physician to take responsibility for
accuracy of gestational age estimates.
Other commercially available data base software
systems are available and have been implemented
for MSAFP screening programs [7] and in vitro
fertilization programs [10]. We have chosen to
create our own program to maintain maximum
flexibility and to allow for incorporation of inter-
pretation and recommendation formulas. We have
found this program to be easy to use and to modify
as future needs become apparent. By combining
this program with other data base programs the
data can also be utilized for other statistical pur-
poses.
Abstract
A computer program was developed for the IBM PC
computer to be used for maternal serum alpha fetopro-
tein screening (MSAFP). This program, written in
BASIC, 1) maintains a data base for patients tested, 2)
allows input and storage of MSAFP results, 3) calculates
the gestational age dependent result in multiple of the
median (MOM), 4) makes an individualized interpreta-
tion of the result based on maternal age, weight and
diabetes, 5) makes an appropriate recommendation for
subsequent action based on the result, and 6) prints a
report containing the above information. In addition,
the program will print a daily log of patients tested,
provides a follow-up sheet to assist in tracking abnormal
results to term, converts the data files into files which
can be easily intergrated into more powerful data base
programs, and generates a monthly statement for billing
purposes. The program can be easily modified by some-
one with minimal training in the BASIC programing
language.
Keywords: AFP, alpha fetoprotein, database, maternal serum alpha fetoprotein, microcomputer, prenatal diagnosis.
Screening maternaler Semm-Alpha-Fetoproteinwerte un-
ter Verwendung eines in BASIC programmierten Mikro-
computers
Grundsätzlich können alle anenzephalen Feten, die
Mehrheit der Fälle mit offener Spina bifida sowie etwa
die Hälfte aller Bauchwanddefekte über ein Screening
der Alpha-Fetoproteinwerte im mütterlichen Serum
(MSAFP) aufgedeckt werden. Darüberhinaus zeigen
neuere Erkenntnisse, daß ein MSAFP-Screening auch
bei der pränatalen Diagnose eines Down-Syndroms und
anderer Trisomien von Bedeutung ist. Dies führte zu
einem dramatischen Anstieg der Anforderungen von
MSAFP-Messungen seitens der Ärzte sowie einer enor-
men Zunahme der klinischen Labore, die diese Messun-
gen durchführen. Jedoch beinhaltet ein MSAFP-Scree-
ning mehr als die Durchführung des Tests und Wieder-
gabe des Ergebnisses. Das Labor muß nicht nur den
AFP-Wert liefern, sondern ihn auch interpretieren sowie
Konsequenzen des Ergebnisses empfehlen. Das betrifft
Kontrolluntersuchungen sowie letztlich Entscheidungen
über den weitern Schwangerschaftsverlauf. Außerdem
muß berücksichtigt werden, daß das AFP vom Gesta-
tionsalter abhängt und materaale Parameter wie Alter,
Gewicht und z. B. ein insulinpflichtiger Diabetes mellitus
(IDDM) einen Einfluß auf das Ergebnis haben. D. h.,
daß das MSAFP-Labor eine auf jede Patientin spezifisch
zugeschnittene Interpretation und Empfehlung liefern
muß. Das Labor braucht daher die adäquaten Daten
von jedem zu testenden Patienten und muß auf deren
Hintergrund den AFP-Wert analysieren, um dem Arzt
ein aussagekräftiges Ergebnis zu liefern. In der vorlie-
genden Arbeit berichten wir über die Entwicklung eines
Computer-Programms, das das MSAFP-Screening-La-
bor bei diesen Aufgaben unterstützt. Dieses in BASIC
aufgezeichnete Programm speichert erstens die Daten
für jeden getesteten Patienten, speichert zweitens alle
MSAFP-Ergebnisse, berechnet drittens den Wert in Ab-
hängigkeit vom Schwangerschaftsalter unter Berücksich-
tigung vieler Medianwerte (MOM), erlaubt viertens eine
individuelle Interpretation im Hinblick auf mütterliches
Alter, Gewicht und Vorhandensein eines IDDM, gibt
fünftens adäquate Empfehlungen für das weitere Vor-
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gehen und druckt zuletzt einen Bericht aus, der alle o. g.
Informationen enthält. Darüberhinaus kann das Pro-
gramm ein Tagesprotokoll von jedem getesteten Patien-
ten ausdrucken und somit eine Hilfe bei der Weiterver-
folgung suspekter Werte bis hin zum Termin sein. Ebenso
können die Medianwerte unterschiedlicher Schwanger-
schaftsalter in regelmäßigen Abständen korrigiert wer-
den. Es stehen epidemiologische Daten bezüglich posi-
tiver und negativer Screening-Raten zur Verfügung, die
als Qualitätskontrollen benutzt werden können, und mo-
natlich können Rechnungsaufstellungen gemacht wer-
den. Die Datenstreifen sind einfach zu handhaben und
können für statistische Manipulationen und Tests leicht
benutzt werden. Sie können problemlos in größere Pro-
gramme integriert werden. Minimale Kenntnisse der
Programmiersprache BASIC reichen aus, um das Pro-
gramm zu modifizieren. Bislang wurde das Programm




AFP, Alpha-Fetoprotein, AFP im maternalen Serum, Datenspeicherung, Mikrocomputer, prä-
natale Diagnose.
Systeme de donnees par micro ordinateur pour l'etude de
l'alpha fceto proteine serique maternelle
Le dosage systematique de Palphafcetoproteine serique
maternelle (MSAFP) pennet de depister virtuellement la
totalite des foetus anencephales, une majorite des cas de
spina bifida ouverts, et environ la moitie des defects de
la poraoi abdominale. Des donnees resentes suggerent
egalement que le dosge systematique de MSAFP peut
aider au diagnostic prenatal de la trisomie 21 et des
autres trisomies. Ces observation ont entraine une ele-
vation importante du nombre de praticiens necessaires
pour les dosages de MSAFP ainsi qu'une augmentation
majeure du nombre du nombre de laboratoires realisant
cet examen.
Cependant, le depistage per MSAFP implique beaucoup
plus d'elements que la simple realisation d'un dosage et
la transmission d'un resultat.
Le laboratoire clinique ne doit pas seulement fournir des
resultats d'AFP mais egalement interpreter ces resultats,
recommander une attitude appropriee fondee sur ces
resultats et assurer un Systeme du suivi approprie,
comportant Tissue de la grossesse. De plus, le resultat
d'MSAFP du Laboratoire necessite une interpretation
et des recommendations specifiquement sur mesures
pour chaque patient du fait de la nature de AFP depen-
dante de Tage gestionnel, et des effets signales du status
maternel (äge, poids, diabete insulino-dependant) sur les
resultats. Tout cela necessite que le laboratoire clinique
qui realise le test MSAFP obtienne et conserve une base
de donnees adequates concernant le patient a tester, qu'il
integre ces donnees aux resultats d'AFP et qu'il fouraisse
au clinicien un rapport fonde sur cette integration. Dans
cet article nous rapportons le developpement d'un pro-
gramme d'ordinateur qui assiste le depistage en labora-
toire de la MSAFP en reunissant ces cirteres. Ce pro-
gramme, ecrit en basic:
1) garde une base de donnees sur les patients testes
2) permet l'entree et le stockage des resultats de MSAFP
3) calcule les resultats dependants de Tage gestationnel
en multiples de la moyenne (MOM)
4) fournit une interpretation individuelle des resultats en
fonction de Tage maternel, du poids et du diabete in-
sulino-dependant
5) procure des recommandations appropriees pour une
Strategie fondee sur ces resultats
6) imprime un rapport contenant les informations ci-
dessus.
En outre, le programme peut imprimer un journal quo-
tidien des patients testes, fournir une feuille de suivi pour
aider au depistage des resultats anormaux ä terme, met
ä jour les valeurs moyennes aux differents äges gesta-
tionnels ä intervalles reguliere, fournit des donnees epi-
demiologiques sur les taux de faux positifs et de faux
negatifs que peut utilisier comme controles de qua-
lite, et il fournit pour la facturation un releve mensuel.
Les disquettes de base de donnees sont simples et
peuvent etre fournies pour des travaux statistiques.
Ces disquettes de donnees peuvent egalement etre inte-
grees aisement dans des programmes de base de donnees
plus puissantes.
Le programme peut aisement etre modifie par quelqu'un
qui possede un minimum d'entramement en basic.
A ce jour, ce programme a ete utilise avec succes pour
Panalyse de plus de 6300 echantilles de MSAFP.
Mots-cles: AFP, alpha fceto proteine, alphafoetoproteine serique maternelle, base de donnees, micro-ordinateur,
diagnostic prenatal.
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